Department of Anesthesia, Teine Keijinkai Hospital, 1-12-1-40 Maeda, Teine, Sapporo, 006-8555, Japan.
J Anesth. 2023 Oct;37(5):769-774. doi: 10.1007/s00540-023-03234-z. Epub 2023 Aug 23.
Several studies indicate that assisted reproductive technology (ART) including in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) pregnancies carries increased risk of complications including postpartum hemorrhage (PPH). However, the association between IVF/ICSI and the bleeding risk particularly in cesarean delivery has not been systematically assessed. The aim of this study was to evaluate bleeding risk during and after cesarean delivery in parturients who conceived using IVF or ICSI.
This is a retrospective observational study analyzing data from 310 parturients who underwent cesarean delivery: 155 who had conceived using IVF or ICSI (IVF/ICSI group) and 155 age and year of delivery matched controls who had conceived spontaneously (control group). The primary outcome measure was the amount of blood lost during and within 24 h after cesarean delivery. Secondary outcome measure was the incidence of severe PPH. With 132 parturients in each group, we had 90% power to detect a 200 mL difference in the bleeding amount, at a 0.05 two-sided significance level.
The amount of bleeding in the IVF/ICSI group was 1234 ± 669 mL, which was 124 mL (11.2%) greater than that in the control group (95% CI - 34 to 282; p = 0.12). The incidence of severe PPH in the IVF/ICSI group and in the control group was 23.9% and 16.8%, respectively (p = 0.16), and the unadjusted odds ratio was 1.6 (95% CI, 0.9-2.7; p = 0.12). No significant independent effect of IVF/ICSI on the bleeding amount and the incidence of severe PPH was observed in multivariable regression analyses (p = 0.22, p = 0.16).
In this study, IVF and ICSI were not associated with increasing risk of bleeding in cesarean delivery.
有几项研究表明,辅助生殖技术(ART)包括体外受精(IVF)和胞浆内单精子注射(ICSI)妊娠会增加并发症的风险,包括产后出血(PPH)。然而,IVF/ICSI 与出血风险之间的关联,特别是在剖宫产中,尚未得到系统评估。本研究旨在评估使用 IVF 或 ICSI 受孕的产妇在剖宫产时和剖宫产后的出血风险。
这是一项回顾性观察性研究,分析了 310 名接受剖宫产的产妇的数据:155 名使用 IVF 或 ICSI 受孕的产妇(IVF/ICSI 组)和 155 名年龄和分娩年份匹配的自然受孕产妇(对照组)。主要观察指标为剖宫产术中及术后 24 小时内失血量。次要观察指标为严重 PPH 的发生率。每组有 132 名产妇,我们有 90%的把握力在 0.05 双侧显著性水平下检测到出血量相差 200 毫升。
IVF/ICSI 组的出血量为 1234±669 毫升,比对照组多 124 毫升(11.2%)(95% CI-34 至 282;p=0.12)。IVF/ICSI 组和对照组严重 PPH 的发生率分别为 23.9%和 16.8%(p=0.16),未调整的优势比为 1.6(95% CI,0.9-2.7;p=0.12)。多变量回归分析显示,IVF/ICSI 对出血量和严重 PPH 的发生率无显著独立影响(p=0.22,p=0.16)。
在这项研究中,IVF 和 ICSI 与剖宫产出血风险增加无关。